Saliva DNA : An alternative biospecimen for single nucleotide polymorphism chromosomal microarray analysis in autism
American Journal of Medical Genetics Part A · 2023
DOI: 10.1002/ajmg.a.63400 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2023. Verfasst von Dale Cameron Wright und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cytogenetics Department, Sydney Genome Diagnostics, Western Sydney Genetics Program, The Children's Hospital at Westmead, Westmead, New South Wales, …. Hauptthemen laut MEDLINE: Autistic Disorder. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Chromosomal microarray analysis (CMA) is typically performed for investigation of autism using blood DNA. However, blood collection poses significant challenges for autistic children with repetitive behaviors and sensory and communication issues, often necessitating physical restraint or sedation. Noninvasive saliva collection offers an alternative, however, no published studies to date have evaluated saliva DNA for CMA in autism. Furthermore, previous reports suggest that saliva is suboptimal for detecting copy number variation. We therefore aimed to evaluate saliva DNA for single nucleotide polymorphism (SNP) CMA in autistic children. Saliva DNA from 48 probands and parents ( n = 133) was obtained with a mean concentration of 141.7 ng/μL. SNP CMA was successful in 131/133 (98.5%) patients from which we correlated the size and accuracy of a copy number variant(s) called between a proband and carrier parent, and for a subgroup ( n = 17 probands) who had a previous CMA using blood sample. There were no discordant copy number variant results between the proband and carrier parent, or the subgroup, however, there was an acceptable mean size difference of 0.009 and 0.07 Mb, respectively. Our findings demonstrate that saliva DNA can be an alternative for SNP CMA in autism, which avoids blood collection with significant implications for clinical practice guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cytogenetics Department, Sydney Genome Diagnostics, Western Sydney Genetics Program, The Children's Hospital at Westmead, Westmead, New South Wales, Australia.
- Specialty of Genomic Medicine, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
- Academic Unit of Infant Child & Adolescent Psychiatry Services (AUCS), South Western Sydney Local Health District, Ingham Institute, Liverpool, Australia.
- Discipline of Psychiatry & Mental Health, School of Clinical Medicine, University of New South Wales, Randwick, New South Wales, Australia.
- Child Development Unit, The Children's Hospital at Westmead, Westmead, New South Wales, Australia.
ORCID-Profile: Dale Cameron Wright
Zitieren
APA
Wright, D. C., Baluyot, M. L., Carmichael, J., Darmanian, A., Jose, N., Ngo, C., Heaps, L. S., Yendle, A., Holman, K., Ziso, S., Khan, F., Masi, A., Silove, N., & Eapen, V. (2023). Saliva DNA : An alternative biospecimen for single nucleotide polymorphism chromosomal microarray analysis in autism. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63400
Vancouver
Wright DC, Baluyot ML, Carmichael J, Darmanian A, Jose N, Ngo C, et al. Saliva DNA : An alternative biospecimen for single nucleotide polymorphism chromosomal microarray analysis in autism. American Journal of Medical Genetics Part A. 2023. doi:10.1002/ajmg.a.63400
BibTeX
@article{Wright2023,
author = {Wright, Dale Cameron and Baluyot, Maria Lourdes and Carmichael, Johanna and Darmanian, Artur and Jose, Ngaire and Ngo, Con and Heaps, Luke St and Yendle, Amber and Holman, Katherine and Ziso, Sylvia and Khan, Feroza and Masi, Anne and Silove, Natalie and Eapen, Valsa},
title = {Saliva DNA : An alternative biospecimen for single nucleotide polymorphism chromosomal microarray analysis in autism},
journal = {American Journal of Medical Genetics Part A},
year = {2023},
doi = {10.1002/ajmg.a.63400}
}
EUVIMED